- Home
- MPTI vs APLT Comparison
MPTI vs APLT Comparison
Compare MPTI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- APLT
- Stock Information
- Founded
- MPTI 1965
- APLT 2016
- Country
- MPTI United States
- APLT United States
- Employees
- MPTI N/A
- APLT N/A
- Industry
- MPTI
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- MPTI
- APLT Health Care
- Exchange
- MPTI Nasdaq
- APLT Nasdaq
- Market Cap
- MPTI 141.5M
- APLT 128.0M
- IPO Year
- MPTI N/A
- APLT 2019
- Fundamental
- Price
- MPTI $50.90
- APLT $0.89
- Analyst Decision
- MPTI
- APLT Buy
- Analyst Count
- MPTI 0
- APLT 7
- Target Price
- MPTI N/A
- APLT $6.10
- AVG Volume (30 Days)
- MPTI 47.7K
- APLT 12.5M
- Earning Date
- MPTI 11-13-2024
- APLT 11-07-2024
- Dividend Yield
- MPTI N/A
- APLT N/A
- EPS Growth
- MPTI 51.57
- APLT N/A
- EPS
- MPTI 2.01
- APLT N/A
- Revenue
- MPTI $46,980,000.00
- APLT N/A
- Revenue This Year
- MPTI $18.43
- APLT N/A
- Revenue Next Year
- MPTI $8.16
- APLT $2,664.24
- P/E Ratio
- MPTI $25.33
- APLT N/A
- Revenue Growth
- MPTI 20.25
- APLT N/A
- 52 Week Low
- MPTI $23.00
- APLT $0.77
- 52 Week High
- MPTI $71.10
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- MPTI 36.84
- APLT 17.48
- Support Level
- MPTI $46.37
- APLT $0.78
- Resistance Level
- MPTI $69.00
- APLT $1.14
- Average True Range (ATR)
- MPTI 4.53
- APLT 0.13
- MACD
- MPTI -2.00
- APLT 0.17
- Stochastic Oscillator
- MPTI 18.92
- APLT 18.17
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.